• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. ENGAGE POROUS FEMORAL SZ 5-LT MED; PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. ENGAGE POROUS FEMORAL SZ 5-LT MED; PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER Back to Search Results
Catalog Number 1-10003-510
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Arthralgia (2355)
Event Date 10/20/2022
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event Description
It was reported that, after a uka surgery had been performed on an unspecified date, the patient complained of chronic pain.A revision surgery was performed on the (b)(6)2022 to treat this adverse event.The patient received a tka system in exchange.
 
Manufacturer Narrative
B3 (date of event), b5 (event description), d6a (date of implantat ion).
 
Event Description
It was reported that, after a uka surgery had been performed on the (b)(6) 2021, the patient complained of chronic pain.A revision surgery was performed on the (b)(6) 2022 to treat this adverse event.The patient received a tka system in exchange.No further information is available at the moment.
 
Manufacturer Narrative
H3, h6: the devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that per complaint details, a revision/conversion to total knee arthroplasty surgery was performed due to patient complaints of chronic pain.An electronic photo of a left unicompartmental knee arthroplasty charstiks sheet (dated (b)(6) 2021) and open surgical wound imaging (dated 10/20) were provided, which would likely indicate revision to be approximately 21 months post implantation; however, the photos do not provide insight into the clinical root cause of the reported event.Of note, the symptom onset date is unknown, and although the wound image date does not correlate with the reported occurrence date of 11/20/2022, this is believed to be only a typographical error in occurrence date (but no clarification has been received to date).Surgical details and if the components had bony integration or were loosened is unknown.The patient impact beyond the reported chronic pain and revision/conversion to total knee arthroplasty could not be determined.No further medical assessment could be rendered at this time.A review of the production records did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history based on the historical data revealed similar previous events, however, no commonalities that would suggest a device deficiency were found.A review of the instructions for use documents for engage partial knee system revealed that pain has been identified in adverse effects and complications.There is not enough data available to conclude that the overall clinical benefit outweighs the potential risk profile when compared to the state of the art.The existing data identifies a potential signal that the performance is an outlier vs the state of the art with respect to the risk for revision.In addition, a historical review concluded that no previous escalated actions for this type of issue were identified.However, as a correction action a voluntary market removal will be performed for the engage cementless partial knee system due recent complaint data that indicates that the revision rate may be trending higher than corresponding similar devices in global joint replacement registries.At this time, we have no reason to suspect that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include traumatic injury, joint tightness, patient condition or postoperative care.Based on this investigation, the need for corrective action may be indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENGAGE POROUS FEMORAL SZ 5-LT MED
Type of Device
PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16554464
MDR Text Key311412844
Report Number1020279-2023-00556
Device Sequence Number1
Product Code HSX
UDI-Device Identifier00885556873014
UDI-Public885556873014
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190439
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 05/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1-10003-510
Device Lot Number100030
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/20/2022
Initial Date FDA Received03/16/2023
Supplement Dates Manufacturer Received11/20/2022
05/18/2023
Supplement Dates FDA Received04/17/2023
05/30/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberRES 92286
Patient Sequence Number1
Treatment
1-10011-300/100071.; 1-10012-500 /100045.; 1-10013-509/100130.
Patient Outcome(s) Required Intervention;
-
-